These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 38037549)
1. The suppressive efficacy of THZ1 depends on KRAS mutation subtype and is associated with super-enhancer activity and the PI3K/AKT/mTOR signalling in pancreatic ductal adenocarcinoma: A hypothesis-generating study. Huang L; Yang H; Chen K; Yuan J; Li J; Dai G; Gu M; Shi Y Clin Transl Med; 2023 Dec; 13(12):e1500. PubMed ID: 38037549 [TBL] [Abstract][Full Text] [Related]
2. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells. Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203 [TBL] [Abstract][Full Text] [Related]
14. PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice. Wu CY; Carpenter ES; Takeuchi KK; Halbrook CJ; Peverley LV; Bien H; Hall JC; DelGiorno KE; Pal D; Song Y; Shi C; Lin RZ; Crawford HC Gastroenterology; 2014 Dec; 147(6):1405-16.e7. PubMed ID: 25311989 [TBL] [Abstract][Full Text] [Related]
15. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice. Jiang SH; Li J; Dong FY; Yang JY; Liu DJ; Yang XM; Wang YH; Yang MW; Fu XL; Zhang XX; Li Q; Pang XF; Huo YM; Li J; Zhang JF; Lee HY; Lee SJ; Qin WX; Gu JR; Sun YW; Zhang ZG Gastroenterology; 2017 Jul; 153(1):277-291.e19. PubMed ID: 28315323 [TBL] [Abstract][Full Text] [Related]
16. Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer. Mortazavi M; Moosavi F; Martini M; Giovannetti E; Firuzi O Crit Rev Oncol Hematol; 2022 Aug; 176():103749. PubMed ID: 35728737 [TBL] [Abstract][Full Text] [Related]
17. Single-cell RNA sequencing reveals the mechanism of PI3K/AKT/mTOR signaling pathway activation in lung adenocarcinoma by KRAS mutation. Xu L; Ding R; Song S; Liu J; Li J; Ju X; Ju B J Gene Med; 2024 Jan; 26(1):e3658. PubMed ID: 38282149 [TBL] [Abstract][Full Text] [Related]
18. ARID1A Maintains Differentiation of Pancreatic Ductal Cells and Inhibits Development of Pancreatic Ductal Adenocarcinoma in Mice. Kimura Y; Fukuda A; Ogawa S; Maruno T; Takada Y; Tsuda M; Hiramatsu Y; Araki O; Nagao M; Yoshikawa T; Ikuta K; Yoshioka T; Wang Z; Akiyama H; Wright CV; Takaori K; Uemoto S; Chiba T; Seno H Gastroenterology; 2018 Jul; 155(1):194-209.e2. PubMed ID: 29604291 [TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity for Kras Ma Y; Li Y; Ling S; Li X; Kong B; Hu M; Huang P Biochem Biophys Res Commun; 2020 Jun; 526(4):880-888. PubMed ID: 32279996 [TBL] [Abstract][Full Text] [Related]
20. Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice. Mohammed A; Qian L; Janakiram NB; Lightfoot S; Steele VE; Rao CV Int J Cancer; 2012 Oct; 131(8):1951-62. PubMed ID: 22287227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]